Login / Signup

High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.

Jian-Wei YunCui WangYi YuHui-Mei XuLing-Zhu GouXiao-Li LiGui-Rong YiYi-Ming LinTi-Yun HanDe-Kui Zhang
Published in: British journal of clinical pharmacology (2022)
C UBT ≥ 20 before treatment were significantly correlated with H. pylori eradication failure.
Keyphrases
  • helicobacter pylori infection
  • high dose
  • helicobacter pylori
  • study protocol
  • low dose
  • stem cell transplantation
  • stem cells
  • clinical trial
  • replacement therapy
  • mesenchymal stem cells
  • smoking cessation